Immunitybio News - November 2026

🔴 Immunitybio is trading at 10.3% down amid broader market and biotech declines

Immunitybio is trading 10.3% down at $8.01 amid steep declines across the broader market and biotech, with no confirmed company announcement directly...

Immunitybio Inc Q3 2026 Earnings Preview: What Analysts Expect on November 03, 2026

Analysts expect ImmunityBio to report Q3 2026 revenue of $59.23 million and a consensus EPS of -$0.07, with shares currently trading at $8.53 against an...